Considering that LINC00346 and miR-188-3p exert opposite effects against pancreatic cancer cells, we hypothesized that the oncogenic activity of LINC00346 may be ascribed to the interaction with miR-188-3p. The gene discussed is PRECSIT; the disease is pancreatic neoplasm.